$BRWC
Birdie Win Corp

2024 Q4 Form 10-Q Financial Statement

#000149315224048236 Filed on December 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2023 Q4
Revenue $10.00K $5.000K
YoY Change 100.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit $10.00K $5.000K
YoY Change 100.0% 0.0%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $16.81K
YoY Change 68.1%
% of Gross Profit 336.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $109.00 $186.00
YoY Change -41.4% 0.0%
% of Gross Profit 1.09% 3.72%
Operating Expenses $10.08K $16.99K
YoY Change -40.66% 162.6%
Operating Profit -$83.00 -$11.99K
YoY Change -99.31% 715.3%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$83.00 -$11.99K
YoY Change -99.31% 1046.56%
Income Tax
% Of Pretax Income
Net Earnings -$83.00 -$11.99K
YoY Change -99.31% 1046.56%
Net Earnings / Revenue -0.83% -239.86%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.760M shares 5.040M shares
Diluted Shares Outstanding 5.760M shares 5.040M shares

Balance Sheet

Concept 2024 Q4 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $990.00
YoY Change -90.1%
Cash & Equivalents $1.927K $989.00
Short-Term Investments
Other Short-Term Assets $3.420K
YoY Change
Inventory
Prepaid Expenses $8.131K $3.415K
Receivables
Other Receivables $0.00
Total Short-Term Assets $10.06K $4.404K
YoY Change 128.38% -80.34%
LONG-TERM ASSETS
Property, Plant & Equipment $28.00 $669.00
YoY Change -95.81% -52.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $28.00 $669.00
YoY Change -95.81% -52.65%
TOTAL ASSETS
Total Short-Term Assets $10.06K $4.404K
Total Long-Term Assets $28.00 $669.00
Total Assets $10.09K $5.073K
YoY Change 98.82% -78.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.685K $2.500K
YoY Change 7.4% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.47K $11.28K
YoY Change -7.23% 0.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.47K $11.28K
Total Long-Term Liabilities $0.00
Total Liabilities $10.47K $11.28K
YoY Change -7.23% 0.93%
SHAREHOLDERS EQUITY
Retained Earnings -$57.98K -$45.81K
YoY Change 26.57% 69.86%
Common Stock $5.760K $5.040K
YoY Change 14.29% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$379.00 -$6.207K
YoY Change
Total Liabilities & Shareholders Equity $10.09K $5.073K
YoY Change 98.82% -78.69%

Cashflow Statement

Concept 2024 Q4 2023 Q4
OPERATING ACTIVITIES
Net Income -$83.00 -$11.99K
YoY Change -99.31% 1046.56%
Depreciation, Depletion And Amortization $109.00 $186.00
YoY Change -41.4% 0.0%
Cash From Operating Activities $83.00 $989.00
YoY Change -91.61% -118.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities $83.00 $989.00
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash $83.00 $989.00
YoY Change -91.61% -119.59%
FREE CASH FLOW
Cash From Operating Activities $83.00 $989.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5760000 shares
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1927 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8131 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10912 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
10058 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12757 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137 usd
CY2024Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
28 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
137 usd
CY2024Q4 us-gaap Assets
Assets
10086 usd
CY2024Q3 us-gaap Assets
Assets
12894 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2685 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5410 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10465 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13190 usd
CY2024Q4 us-gaap Liabilities
Liabilities
10465 usd
CY2024Q3 us-gaap Liabilities
Liabilities
13190 usd
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5760000 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5760000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5760000 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
5760 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5760 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51840 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51840 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57979 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57896 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-379 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-296 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10086 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12894 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-11993 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83 usd
CY2024Q4 dei Amendment Flag
AmendmentFlag
false
CY2024Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2024Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001873213
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2024Q4 us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
usd
CY2024Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q4 us-gaap Stock Issued1
StockIssued1
usd
CY2023Q4 us-gaap Stock Issued1
StockIssued1
usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q4 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q4 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
usd
CY2024Q4 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
usd
CY2024Q4 dei Document Type
DocumentType
10-Q
CY2024Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q4 dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
CY2024Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q4 dei Entity File Number
EntityFileNumber
333-259112
CY2024Q4 dei Entity Registrant Name
EntityRegistrantName
BIRDIE WIN CORPORATION
CY2024Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-4179726
CY2024Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
Unit 8, 6/F, Wayson Commercial Building
CY2024Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
28 Connaught Road West
CY2024Q4 dei Entity Address Country
EntityAddressCountry
HK
CY2024Q4 dei City Area Code
CityAreaCode
(+86)
CY2024Q4 dei Local Phone Number
LocalPhoneNumber
13824472731
CY2024Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1845 usd
CY2024Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
7780 usd
CY2024Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
7780 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5760000 shares
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9974 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16807 usd
CY2024Q4 us-gaap Depreciation
Depreciation
109 usd
CY2023Q4 us-gaap Depreciation
Depreciation
186 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
10083 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
16993 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-83 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-11993 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-11993 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5760000 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5760000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5040000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5040000 shares
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-296 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-379 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5786 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5786 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-11993 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6207 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6207 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83 usd
CY2024Q4 us-gaap Depreciation
Depreciation
109 usd
CY2023Q4 us-gaap Depreciation
Depreciation
186 usd
CY2023Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
10000 usd
CY2024Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2781 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
694 usd
CY2024Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2725 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2500 usd
CY2023Q4 us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
5990 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
989 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
83 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
989 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1845 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1927 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
989 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3600 usd
CY2021Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
120000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1440000 shares
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.025
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
36000 usd
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
36000 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57979 usd
CY2024Q4 BRWC Working Capital Deficit
WorkingCapitalDeficit
-407 usd
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zPb6llgojari" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zRusc0ovp2L">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10000 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10000 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
CY2024Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10000 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10000 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8131 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10912 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8131 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10912 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8131 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10912 usd
CY2024Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2231 usd
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2231 usd
CY2024Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2203 usd
CY2024Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2094 usd
CY2024Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
28 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
137 usd
CY2024Q4 us-gaap Depreciation
Depreciation
109 usd
CY2023Q4 us-gaap Depreciation
Depreciation
186 usd
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13000 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5760000 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5760000 shares
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2024Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
83 usd
CY2023Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11993 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11993 usd
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.35 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2024Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
57979 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12176 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
12176 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
12158 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
12176 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
12158 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12176 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12158 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12176 usd
CY2024Q4 us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
The Company has single reportable segment based on business unit, financial services business and two reportable segments based on country, Malaysia and Hong Kong
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
10083 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-83 usd
CY2024Q4 us-gaap Assets
Assets
10086 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
16993 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-11993 usd
CY2023Q4 us-gaap Assets
Assets
5073 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
10083 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-83 usd
CY2024Q4 us-gaap Assets
Assets
10086 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
16993 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-11993 usd
CY2023Q4 us-gaap Assets
Assets
5073 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57979 usd
CY2024Q4 BRWC Working Capital Deficit
WorkingCapitalDeficit
-407 usd

Files In Submission

Name View Source Status
brwc-20241031_lab.xml Edgar Link unprocessable
0001493152-24-048236-index-headers.html Edgar Link pending
0001493152-24-048236-index.html Edgar Link pending
0001493152-24-048236.txt Edgar Link pending
0001493152-24-048236-xbrl.zip Edgar Link pending
brwc-20241031.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
brwc-20241031_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
brwc-20241031_def.xml Edgar Link unprocessable
brwc-20241031_cal.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending